OpenBook
powered by Huma.ai
PREDICTIVE SITE INTELLIGENCE
Critical Trial Context Is Trapped in Siloed Inboxes. Stop Troubleshooting Reactively.
86% of clinical trials face costly delays due to invisible site friction. OpenBook gives you predictive site intelligence to protect your enrollment milestones—without adding administrative burden or changing site workflows.
Zero Site Retraining • 0 New Logins • Deploy in Under 14 Days
01 / THE REALITY
The Operational Blind Spot in Clinical Trials
Your trials move fast, but critical context disappears across fragmented threads, leaving ClinOps teams chasing updates instead of proactively enabling sites.
01
Buried Inboxes & Fragmented Messages
Critical site friction and unrecorded complaints sit buried in unread threads and daily messages until enrollment stalls.
02
The 3–4 Week Reporting Lag
In-person monitor insights and trip reports arrive weeks late, revealing site issues long after they should have been resolved.
03
Site Portal Fatigue
Trial sites are overwhelmed by software overload and actively resist adopting new tools, log-ins, or complicated portals.
86%
Clinical trials delayed due to unaddressed site issues.
11%-13%
Activated sites that enroll zero patients, wasting up to $50K+ in startup capital per site.
21 Days Early
The window in which OpenBook can identify site disengagement and protocol friction before enrollment stalls.
02 / A CLEARER WAY FORWARD
Transform Reactive Firefighting into Proactive Site Health
Keep your active trials on schedule with continuous, zero-friction visibility with OpenBook
01
Detect Study Friction Early
Identify site confusion and protocol ambiguity before they cause protocol deviations or enrollment freezes.
02
Protect Site Engagement
Recognize warning signs of investigator disengagement days or weeks before traditional systems register an issue.
03
Zero Site Disruption
Zero software for investigators to install, zero logins to manage, and zero workflow changes for site coordinators.
03 / CLOSED DESIGN PARTNERSHIPS
Deploy OpenBook on an Active Mid-Flight Study in Under 14 Days
We are partnering with select biotech clinical operations teams for closed design partnerships. Experience zero-friction site visibility on an ongoing trial.